Position in ZTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$12,517,254
-$9,552,578 QoQ
Shares Held
105,890
-39.6% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Federation des caisses Desjardins du Quebec holds $37,941,198 across 32 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (33.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
105,890 | $12,517,254 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
285,623 | $8,602,962 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
11,255 | $6,673,988 | |
| 4 | ALKS |
Alkermes plc.
|
66,144 | $2,338,851 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
26,930 | $2,070,915 | |
| 6 | VTRS |
Viatris Inc
|
94,833 | $1,281,191 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
51,137 | $1,223,707 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
8,564 | $1,128,218 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,517,254 | 105,890 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $22,069,832 | 175,408 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $27,452,409 | 187,619 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $51,780,075 | 332,030 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $50,622,792 | 307,457 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $58,141,731 | 356,851 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $72,455,695 | 370,845 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $91,343,036 | 526,898 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $56,700,239 | 335,088 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $41,991,256 | 212,754 | Shares | Defined | 2024-08-15 | |
| 2023-09-30 | $40,072,986 | 230,331 | Shares | Defined | 2024-08-15 | |
| 2023-06-30 | $25,542,014 | 148,319 | Shares | Defined | 2024-08-15 | |
| 2023-03-31 | $22,549,456 | 135,481 | Shares | Defined | 2024-08-15 | |
| 2022-12-31 | $11,700,258 | 79,838 | Shares | Defined | 2024-08-15 | |
| 2022-09-30 | $5,245,610 | 35,374 | Shares | Defined | 2024-08-15 | |
| 2022-06-30 | $6,034,885 | 35,109 | Shares | Defined | 2024-08-15 | |
| 2022-03-31 | $6,472,974 | 34,323 | Shares | Defined | 2024-08-15 | |
| 2021-12-31 | $8,088,373 | 33,145 | Shares | Defined | 2024-08-30 | |
| 2021-09-30 | $6,700,352 | 34,513 | Shares | Defined | 2024-08-30 | |
| 2021-06-30 | $6,819,657 | 36,594 | Shares | Defined | 2024-08-30 | |
| 2021-03-31 | $5,871,169 | 37,282 | Shares | Defined | 2024-08-30 | |
| 2020-12-31 | $2,531,819 | 15,298 | Shares | Defined | 2024-08-30 | |
| 2020-09-30 | $1,305,926 | 7,897 | Shares | Defined | 2024-08-30 | |
| 2020-06-30 | $1,143,187 | 8,342 | Shares | Defined | 2024-08-30 | |
| 2020-03-31 | $1,028,492 | 8,739 | Shares | Defined | 2024-08-30 | |
| No filing history on record for this holder in this stock. | ||||||